Generative-biology company using diffusion models to design novel protein therapeutics from scratch.
Computational de novo protein and enzyme design company spun out of David Baker's University of Washington lab.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →